AvKARE has voluntarily recalled 1,016 cartons of Nitrofurantoin Capsules, USP (100 mg), a medication used to treat bacterial infections. The recall was issued because the capsules failed dissolution testing, meaning they may not dissolve properly in the body as required. Each recalled carton contains 50 unit-dose capsules.
If the capsules do not dissolve correctly, the patient may not receive the intended dose of medication. This could lead to the antibiotic being ineffective, resulting in a failure to treat the infection.
You have 2 options:
Recall #: D-0168-2025; Manufactured for AvKARE, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.